Mark Makowsky, BSP, PharmD.

Assistant Professor, Faculty of Pharmacy & Pharmaceutical Sciences


Assistant Professor, Faculty of Pharmacy & Pharmaceutical Sciences
(780) 492-1735
3-224 Edmonton Clinic Health Academy
11405 - 87 Ave NW
Edmonton AB
T6G 1C9




Post Doctoral Research Fellowship, EPICORE Centre/COMPRIS, University of Alberta (2007)

Doctor of Pharmacy, University of British Columbia (2005)

Pharmacy Practice Resident, Winnipeg Regional Health Authority (2000)

Bachelor of Science in Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan (1998)


Alberta College of Pharmacists

Pharmacy Examining Board of Canada


Association of Faculties of Pharmacy of Canada, Canadian Society of Hospital Pharmacists, Canadian Pharmacists Association, Hypertension Canada, North American Primary Care Research Group 


Dr. Makowsky maintains a high-level, innovative, integrated and collaborative clinical practice in primary care at an academic family medicine clinic. He maintains a generalist medication management service and actively manages patient pharmacotherapy by having the ability to prescribe Schedule 1 medications and order lab tests.     



e-Health, Primary Care, Hypertension, Diabetes, Health Services Research, Interdisciplinary Practice, Sports Pharmacy 

Dr. Makowsky’s research program in centered in primary care and has focused on 3 main areas: 

1. Understanding how novel technologies (e.g., the internet, smartphones, social media, and applications) influence patient engagement in self-management, shared decision making, and healthcare outcomes. 

2. Evaluating approaches to optimize drug therapy decision-making and quality of patient medication use in primary care. 

3. Developing and evaluating novel strategies to improve the prevention and treatment of hypertension.  

A listing of his works in Pubmed is found here.


Dr. Makowsky teaches in the areas of evidence-based clinical practice, pharmacotherapeutics, and pharmacy practice. Clinical areas of expertise include: Hypertension and cardiovascular risk reduction, smoking cessation, peptic ulcer disease, dyspepsia, chronic pain management, osteoarthritis, asthma and COPD. He coordinates: PHARM 324 – Evidence-Based Medicine in the undergraduate curriculum and PHARM 501  – Critical Analysis of Evidence in Practice in the PharmD cirriculum  He is also very active in supervising undergraduate and PharmD students in his practice site. 


PHARM 312 - Behavioural, Administrative, Social and Evidence-based Pharmacy 3

Students will apply ethical frameworks, the legal system, and roles of pharmacy organizations in pharmacy practice. Students will develop skills in creating educational plans, appraising randomized controlled trials, and using written patient information. (Restricted to Pharmacy students.)

Fall Term 2020
PHARM 501 - Critical Analysis of Evidence in Practice

Focus is on the synthesis of evidence from various sources and addresses complex issues in pharmacy practice to build on the student's understanding of study design, evidence-based clinical practice, and critical appraisal. Students will gain experience by using a variety of information sources to discuss drug information assignments and practice enhancement issues. Sections offered in a Cost Recovery format at an increased rate of fee assessment; refer to the Fees Payment Guide in the University Regulations and Information for Students section of the Calendar. (Restricted to PharmD Students or with Faculty consent.)

Fall Term 2020

Browse more courses taught by Mark Makowsky